Selegiline in Treatment of Cocaine Dependence - 2

University of Pennsylvania

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Selegiline

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000188

NIDA-00144-2

K20-00144-2

3R01DA012268 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.

Enrollment: 50 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind